Delayed age at menarche in chronic respiratory diseases.
adolescence
asthma
cystic fibrosis
inflammatory cytokines
Journal
European journal of clinical investigation
ISSN: 1365-2362
Titre abrégé: Eur J Clin Invest
Pays: England
ID NLM: 0245331
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
revised:
18
10
2020
received:
09
06
2020
accepted:
22
11
2020
pubmed:
29
11
2020
medline:
15
12
2021
entrez:
28
11
2020
Statut:
ppublish
Résumé
Age at menarche (AAM) is an important indicator of physiological development in women, and delayed AAM has been associated with chronic illnesses. We investigated predictive factors at diagnosis that influence AAM in adolescents with chronic respiratory diseases. AAM was assessed in 1207 northern Italian female aged 11-24 (1062 healthy, 98 with asthma and 47 with cystic fibrosis [CF]). AAM was defined by recall and status quo methods. We studied anthropometric data, metabolic status, diagnosis parameters, presence of irregular menses. Clinical data of subjects with chronic respiratory illness were compared with that of healthy adolescents. Mean AAM for healthy adolescents was 12.49 ± 1.2 years. Mother's AAM was positively associated with that of their daughters (P < .001). BMI was negatively correlated with AAM (P < .001). 69% of healthy adolescents referred regular menses. AAM in the different groups was 12.79 ± 3.0 years for patients with asthma (P < .05 vs healthy) and 13.24 ± 1.44 years for adolescents with CF (P < .0001 vs healthy). In the asthmatic group, 57% of the patients referred regular menses, and no significant differences were found between AAM and control of the disease (ACT test). In the CF group, no correlation was found between the type of CFTR mutation or FEV1% and AAM. 53% of the patients with CF referred regular menses. AAM in patients with CF and asthma was significantly higher than in healthy adolescents, and menses abnormalities were observed in the last two groups. Inflammation influences the reproductive function in chronic respiratory disease.
Substances chimiques
CFTR protein, human
0
Cystic Fibrosis Transmembrane Conductance Regulator
126880-72-6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13461Informations de copyright
© 2020 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
Références
Weiss. Genes over time and space. In: Lasker GW, Foley RA, Mascie-Taylor CGN, Roberts DF, eds. Genet Var Hum Dis Princ Evol approaches. 1999:153-179.
Talma H, Schönbeck Y, van Dommelen P, et al. Trends in menarcheal age between 1955 and 2009 in the Netherlands. PLoS One. 2013;8(4):e60056.
Morris DH, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Secular trends in age at menarche in women in the UK born 1908-93: results from the Breakthrough Generations Study. Paediatr Perinat Epidemiol. 2011;25(4):394-400. https://doi.org/10.1111/j.1365-3016.2011.01202.x
Rigon F, Bianchin L, Bernasconi S, et al. Update on age at menarche in Italy: toward the leveling off of the secular trend. J Adolesc Health. 2010;46(3):238-244. https://doi.org/10.1016/j.jadohealth.2009.07.009
Parent A-S, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon J-P. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocrine Rev. 2003;24(5):668-693. https://doi.org/10.1210/er.2002-0019
Gajdos ZKZ, Henderson KD, Hirschhorn JN, Palmert MR. Genetic determinants of pubertal timing in the general population. Mol Cell Endocrinol. 2010;324(1-2):21-29. https://doi.org/10.1016/j.mce.2010.01.038
He C, Murabito JM. Genome-wide association studies of age at menarche and age at natural menopause. Mol Cell Endocrinol. 2014;382(1):767-779. https://doi.org/10.1016/j.mce.2012.05.003
van den Berg SM, Boomsma DI. The familial clustering of age at menarche in extended twin families. Behav Genet. 2007;37(5):661-667. https://doi.org/10.1007/s10519-007-9161-4
Prentice S, Fulford AJ, Jarjou LMA, Goldberg GR, Prentice A. Evidence for a downward secular trend in age of menarche in a rural Gambian population. Ann Hum Biol. 2010;37(5):717-721. https://doi.org/10.3109/03014461003727606
Terry MB, Ferris JS, Tehranifar P, Wei Y, Flom JD. Birth weight, postnatal growth, and age at menarche. Am J Epidemiol. 2009;170(1):72-79. https://doi.org/10.1093/aje/kwp095
Iwasa T, Matsuzaki T, Murakami M, et al. Effects of intrauterine undernutrition on hypothalamic Kiss1 expression and the timing of puberty in female rats. J Physiol. 2010;588(Pt 5):821-829. https://doi.org/10.1113/jphysiol.2009.183558
Canoy D, Beral V, Balkwill A, et al. Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort. Circulation. 2015;131(3):237-244. https://doi.org/10.1161/CIRCULATIONAHA.114.010070
Day FR, Elks CE, Murray A, Ong KK, Perry JRB. Puberty timing associated with diabetes, cardiovascular disease and also diverse health outcomes in men and women: The UK Biobank study. Sci Rep. 2015;5:11208. https://doi.org/10.1038/srep11208
Hartge P. Genetics of reproductive lifespan. Nat Genet. 2009;41(6):637-638. https://doi.org/10.1038/ng0609-637
Karapanou O, Papadimitriou A. Determinants of menarche. Reprod Biol Endocrinol. 2010;8:115. https://doi.org/10.1186/1477-7827-8-115
Caverly LJ, Huang YJ, Sze MA. Past, present, and future research on the lung microbiome in inflammatory airway disease. Chest. 2019;156(2):376-382. https://doi.org/10.1016/j.chest.2019.05.011
Johannesson M, Gottlieb C, Hjelte L. Delayed puberty in girls with cystic fibrosis despite good clinical status. Pediatrics. 1997;99(1):29-34.
Umławska W, Sands D, Zielińska A. Age of menarche in girls with cystic fibrosis. Folia Histochem Cytobiol. 2010;48(2):185-190.
Moudiou T, Theophilatou D, Priftis K, Papadimitriou A. Growth of asthmatic children before long-term treatment with inhaled corticosteroids. J Asthma. 2003;40(6):667-671.
Drosdzol A, Skrzypulec V, Wilk K, Nowosielski K. The influence of bronchial asthma on sexual maturation of girls. J Physiol Pharmacol. 2007;58 Suppl 5(Pt 1):155-163.
Murri V, Antoniazzi F, Piazza M, et al. Lung function in women with idiopathic central precocious puberty: a pilot study. Horm Res Paediatr. 2017;87(2):95-102. https://doi.org/10.1159/000454729
Nguyen VN, Chavannes N, Le Tuyet LT, Price D. The Asthma Control Test (ACT) as an alternative tool to Global Initiative for Asthma (GINA) guideline criteria for assessing asthma control in Vietnamese outpatients. Prim Care Respir J. 2011;21(1):85-89. https://doi.org/10.4104/pcrj.2011.00093
Johannesson M, Landgren BM, Csemiczky G, Hjelte L, Gottlieb C. Female patients with cystic fibrosis suffer from reproductive endocrinological disorders despite good clinical status. Hum Reprod. 1998;13(8):2092-2097.
Sadowska L, Lewandowska J, Waliszko A, Domanasiewicz M. [Evaluation of the development and sex maturation of children with bronchial asthma from the Upper Silesia based on many years’ observation]. Pediatr Pol. 1986;61(11):717-724.
Drosdzol A, Skrzypulec V, Wilk K, Rachel M. The influence of bronchial asthma on menstrual cycle. J Physiol Pharmacol. 2007;58 Suppl 5(Pt 1):165-173.
Larson-Nath C, Goday P. Malnutrition in children with chronic disease. Nutr Clin Pract. 2019;34(3):349-358.
Pozo J, Argente J. Delayed puberty in chronic illness. Best Pract Res Clin Endocrinol Metab. 2002;16(1):73-90.
Street ME, Ziveri MA, Spaggiari C, et al. Inflammation is a modulator of the insulin-like growth factor (IGF)/IGF-binding protein system inducing reduced bioactivity of IGFs in cystic fibrosis. Eur J Endocrinol. 2006;154(1):47-52.
Giudice LC. Insulin-like growth factors and ovarian follicular development. Endocr Rev. 1992;13(4):641-669.
Acat M, Erbay UT, Sahin S, Arik O, Ayada C. High serum levels of IGF-I and IGFBP3 may increase comorbidity risk for asthmatic patients. Bratislava Med J. 2017;118(11):691-694. https://doi.org/10.4149/BLL_2017_130
Peters MC, McGrath KW, Hawkins GA, et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir Med. 2016;4(7):574-584.
Berry M, Brightling C, Pavord I, Wardlaw A. TNF-α in asthma. Curr Opin Pharmacol. 2007;7(3):279-282.
Schmitt-Grohé S, Stüber F, Book M, et al. TNF-α promoter polymorphism in relation to TNF-α production and clinical status in cystic fibrosis. Lung. 2006;184(2):99-104.
Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev. 1999;79(1):1-71.
Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004;130(4):601-630.
Frisch RE, Revelle R. Height and weight at menarche and a hypothesis of menarche. Arch Dis Child. 1971;46(249):695-701.
Goon DT, Toriola AL, Uever J, Wuam S, Toriola OM. Growth status and menarcheal age among adolescent school girls in Wannune, Benue State, Nigeria. BMC Pediatr. 2010;10(1):60.
Frisch RE, McArthur JW. Menstrual cycles: Fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science. 1974;185(4155):949-951.
Dorn LD, Sontag-Padilla LM, Pabst S, Tissot A, Susman EJ. Longitudinal reliability of self-reported age at menarche in adolescent girls: variability across time and setting. Dev Psychol. 2013;49(6):1187-1193.
Giordani B, Amato A, Majo F, et al. Registro italiano Fibrosi Cistica (RIFC). Rapporto 2015-2016. Epidemiol Prev. 2019;43(4S1):1-36.